FDG PET/CT in colorectal cancer. / FDG PET/TC en el cáncer colorrectal.
Rev Esp Med Nucl Imagen Mol (Engl Ed)
; 39(1): 57-66, 2020.
Article
in En, Es
| MEDLINE
| ID: mdl-31776063
ABSTRACT
Colorectal cancer is the third most frequent cancer worldwide. Although its incidence is increasing, mainly in those aged under50, mortality has decreased by 50% in the more developed countries, principally due to the adoption of new practices in prevention, diagnosis and treatment. In particular, the various diagnostic imaging modalities allow improved therapeutic decision-making, evaluation of the response and early detection of recurrence. The aim of this paper is to review the available scientific evidence on the value of positron emission tomography with 18F-FDG (18F-FDG PET/CT) in the colorectal cancer, with special emphasis on the indications of the guidelines and recommendations of the main international scientific associations regarding this imaging technique.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rectal Neoplasms
/
Colonic Neoplasms
/
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Positron Emission Tomography Computed Tomography
Type of study:
Guideline
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
En
/
Es
Journal:
Rev Esp Med Nucl Imagen Mol (Engl Ed)
Year:
2020
Document type:
Article